View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Chronic Hepatitis News

SPONSORED CONTENT
January 17, 2025
2 min read
Save
People with HBV, HIV coinfection at risk for hepatitis D ‘superinfection’

People with HBV, HIV coinfection at risk for hepatitis D ‘superinfection’

Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D, which is associated with an increased risk of liver-related complications and mortality, researchers found.

SPONSORED CONTENT
January 07, 2025
2 min read
Save

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients hospitalized for alcohol use disorder were more likely to develop alcohol-associated hepatitis, decompensated cirrhosis and related complications compared with non-Hispanic white patients, according to published data.

SPONSORED CONTENT
December 23, 2024
1 min read
Save

CDC: Heplisav-B joins recommended HBV vaccine options for pregnant patients

CDC: Heplisav-B joins recommended HBV vaccine options for pregnant patients

Data from a postlicensure study support the CDC’s recommendation that Heplisav-B can now be administered to pregnant persons needing hepatitis B vaccination, as its use did not appear to increase risk for major birth defects or miscarriage.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
December 06, 2024
2 min read
Save

HCC incidence nearly 5-times higher among HBV, HDV coinfected patients with cirrhosis

HCC incidence nearly 5-times higher among HBV, HDV coinfected patients with cirrhosis

Incidence of hepatocellular carcinoma was significantly higher among cirrhotic patients coinfected with hepatitis B and D viruses compared with those with HBV alone, with researchers suggesting HDV “plays a direct role” in HCC occurrence.

SPONSORED CONTENT
December 05, 2024
2 min read
Save

‘Only one in six’ veterans with chronic HBV finish HDV testing despite severe disease risk

‘Only one in six’ veterans with chronic HBV finish HDV testing despite severe disease risk

Among veterans with chronic hepatitis B virus infection, rates of hepatitis D virus testing were low and those with concurrent infection were at greater risk for cirrhosis and hepatic decompensation, according to study results.

SPONSORED CONTENT
November 20, 2024
4 min watch
Save

VIDEO: Combination tobevibart, elebsiran induces ‘rapid virologic suppression’ in HDV

VIDEO: Combination tobevibart, elebsiran induces ‘rapid virologic suppression’ in HDV

SAN DIEGO — Combination tobevibart and elebsiran led to “profound and rapid virologic suppression” as well as normalization of alanine aminotransferase at week 24 in chronic hepatitis D virus infection, according to preliminary data.

SPONSORED CONTENT
November 17, 2024
2 min read
Save

Resuming antiviral therapy after withdrawal does not affect HBsAG seroclearance in HBV

Resuming antiviral therapy after withdrawal does not affect HBsAG seroclearance in HBV

SAN DIEGO — Retreatment with nucleos(t)ide analogue therapy for relapse after withdrawal did not affect hepatitis B surface antigen seroclearance among patients with chronic HBV infection, according to a researcher at The Liver Meeting.

SPONSORED CONTENT
November 04, 2024
2 min watch
Save

VIDEO: Simplified screening, treatment strategies critical in HBV

VIDEO: Simplified screening, treatment strategies critical in HBV

PHILADELPHIA — Paul Kwo, MD, professor of medicine at Stanford University, speaks with Healio about presentations investigating the undertreatment of hepatitis B.

SPONSORED CONTENT
September 10, 2024
2 min read
Save

HBeAg-seroconversion in childhood among predictors of functional cure of chronic HBV

HBeAg-seroconversion in childhood among predictors of functional cure of chronic HBV

Hepatitis B e-antigen seroconversion in childhood and low hepatitis B surface antigen titers after seroconversion independently predicted functional cure in chronic HBV-infected patients followed from childhood through adulthood.

SPONSORED CONTENT
August 30, 2024
2 min read
Save

Even with HCV cure, surveillance for portal hypertension, HCC ‘should be mandatory’

Even with HCV cure, surveillance for portal hypertension, HCC ‘should be mandatory’

Despite achieving cure with direct-acting antivirals, patients with chronic hepatitis C virus-related decompensated cirrhosis remain at risk for progression of portal hypertension, further decompensation and hepatocellular carcinoma.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails